Axsome Therapeutics, Inc. (AXSM)
189.06
+4.56
(+2.47%)
USD |
NASDAQ |
Jan 21, 16:00
188.70
-0.36
(-0.19%)
After-Hours: 16:10
Axsome Therapeutics Cash from Investing (Quarterly): -0.058M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 14.64M |
| Gilead Sciences, Inc. | -427.00M |
| Vanda Pharmaceuticals, Inc. | 21.36M |
| Amicus Therapeutics, Inc. | -1.299M |
| MannKind Corp. | -25.06M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.046M |
| Cash from Financing (Quarterly) | 21.27M |
| Free Cash Flow | -101.39M |
| Free Cash Flow Per Share (Quarterly) | 0.0198 |
| Free Cash Flow to Equity (Quarterly) | 5.778M |
| Free Cash Flow to Firm (Quarterly) | 4.363M |
| Free Cash Flow Yield | -1.09% |